Literature DB >> 25982925

A Potent Multi-functional Neuroprotective Derivative of Tetramethylpyrazine.

Hai-Yun Chen1, Da-Ping Xu2, Guo-Lian Tan1, Wei Cai1, Gao-Xiao Zhang1, Wei Cui2, Jin-Zhao Wang3, Cheng Long3, Ye-Wei Sun1, Pei Yu1, Karl Wahkeung Tsim4, Zai-Jun Zhang5,6, Yi-Fan Han7,8, Yu-Qiang Wang1.   

Abstract

Neurodegenerative disorders are one of the leading causes of death among the elderly. Therapeutic approaches with a single target have proven unsuccessful in treating these diseases. Structural combination of multi-functional compounds may lead to a molecule with multiple properties. In this study, we designed and synthesized T-006, a novel analog derived from two multi-functional neuroprotective chemicals, tetramethylpyrazine and J147. The methoxyphenyl group of J147 was replaced by tetramethylpyrazine. Bioactivity evaluation showed that T-006 at very low concentrations had multi-functional neuroprotective effects including rescuing iodoacetic acid-induced neuronal loss, preventing oxidative stress-induced neurotoxicity and reducing glutamate-induced excitotoxicity in vitro. Most importantly, T-006 significantly ameliorated memory impairments in APP/PS1 transgenic mice. These multiple functions of a single molecule suggest that T-006 is a promising novel neuroprotective agent for treating various neurodegenerative disorders, including and in particular Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25982925     DOI: 10.1007/s12031-015-0566-x

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  30 in total

Review 1.  Alzheimer's disease: strategies for disease modification.

Authors:  Martin Citron
Journal:  Nat Rev Drug Discov       Date:  2010-05       Impact factor: 84.694

Review 2.  The evolving role of natural products in drug discovery.

Authors:  Frank E Koehn; Guy T Carter
Journal:  Nat Rev Drug Discov       Date:  2005-03       Impact factor: 84.694

Review 3.  Alzheimer's disease.

Authors:  Clive Ballard; Serge Gauthier; Anne Corbett; Carol Brayne; Dag Aarsland; Emma Jones
Journal:  Lancet       Date:  2011-03-01       Impact factor: 79.321

Review 4.  Metabolomics of human brain aging and age-related neurodegenerative diseases.

Authors:  Mariona Jové; Manuel Portero-Otín; Alba Naudí; Isidre Ferrer; Reinald Pamplona
Journal:  J Neuropathol Exp Neurol       Date:  2014-07       Impact factor: 3.685

5.  Effect of basic fibroblast growth factor on hippocampal cholinergic neurons in a rodent model of ischaemic encephalopathy.

Authors:  Jianxin Ye; Hang Lin; Junshan Mu; Xiaoping Cui; Hongbing Ying; Min Lin; Lei Wu; Jing Weng; Xiaoshu Lin
Journal:  Basic Clin Pharmacol Toxicol       Date:  2010-12       Impact factor: 4.080

Review 6.  Oxidative stress signalling in Alzheimer's disease.

Authors:  Xiongwei Zhu; Arun K Raina; Hyoung-Gon Lee; Gemma Casadesus; Mark A Smith; George Perry
Journal:  Brain Res       Date:  2004-03-12       Impact factor: 3.252

7.  Dysideamine, a new sesquiterpene aminoquinone, protects hippocampal neuronal cells against iodoacetic acid-induced cell death.

Authors:  Hideaki Suna; Masayoshi Arai; Yoshie Tsubotani; Asami Hayashi; Andi Setiawan; Motomasa Kobayashi
Journal:  Bioorg Med Chem       Date:  2009-04-18       Impact factor: 3.641

8.  Age-correlated gene expression in normal and neurodegenerative human brain tissues.

Authors:  Kajia Cao; Alice S Chen-Plotkin; Joshua B Plotkin; Li-San Wang
Journal:  PLoS One       Date:  2010-09-29       Impact factor: 3.240

9.  A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease.

Authors:  Qi Chen; Marguerite Prior; Richard Dargusch; Amanda Roberts; Roland Riek; Cédric Eichmann; Chandramouli Chiruta; Tatsuhiro Akaishi; Kazuho Abe; Pamela Maher; David Schubert
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

10.  The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice.

Authors:  Marguerite Prior; Richard Dargusch; Jennifer L Ehren; Chandramouli Chiruta; David Schubert
Journal:  Alzheimers Res Ther       Date:  2013-05-14       Impact factor: 6.982

View more
  14 in total

1.  Potent Protection Against MPP+-Induced Neurotoxicity via Activating Transcription Factor MEF2D by a Novel Derivative of Naturally Occurring Danshensu/Tetramethylpyrazine.

Authors:  Shengquan Hu; Liang Wang; Shinghung Mak; Zaijun Zhang; Daping Xu; Haitao Li; Yide Li; Yuanjia Hu; Simon Ming Yuen Lee; Yuqiang Wang; Yifan Han
Journal:  Neuromolecular Med       Date:  2016-06-08       Impact factor: 3.843

2.  A novel curcumin derivative for the treatment of diabetic neuropathy.

Authors:  Daniel J Daugherty; Alexandra Marquez; Nigel A Calcutt; David Schubert
Journal:  Neuropharmacology       Date:  2017-11-06       Impact factor: 5.250

3.  Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson's Disease Models.

Authors:  Hefeng Zhou; Min Shao; Baojian Guo; Chuwen Li; Yucong Lu; Xuanjun Yang; Haitao Li; Qi Zhu; Hanbing Zhong; Yuqiang Wang; Zaijun Zhang; Jiahong Lu; Simon Ming-Yuen Lee
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 4.  Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment.

Authors:  Xiaopeng Ai; Xing Dong; Ying Guo; Peng Yang; Ya Hou; Jinrong Bai; Sanyin Zhang; Xiaobo Wang
Journal:  Purinergic Signal       Date:  2021-03-22       Impact factor: 3.765

5.  The Tetramethylpyrazine Analogue T-006 Alleviates Cognitive Deficits by Inhibition of Tau Expression and Phosphorylation in Transgenic Mice Modeling Alzheimer's Disease.

Authors:  Guiliang Zhang; Jiahui Wu; Chunhui Huang; Jiehong Cheng; Zhiyang Su; Zeyu Zhu; Xifei Yang; Baojian Guo; Liangmiao Wu; Zaijun Zhang; Gaoxiao Zhang; Haiyun Chen; Yewei Sun; Yuqiang Wang
Journal:  J Mol Neurosci       Date:  2021-01-05       Impact factor: 3.444

Review 6.  Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine.

Authors:  Xinhua Zhou; Guozhen Cui; Hisa Hui Ling Tseng; Simon Ming-Yuen Lee; George Pak Heng Leung; Shun Wan Chan; Yiu Wa Kwan; Maggie Pui Man Hoi
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-23       Impact factor: 2.629

7.  A Novel Tetramethylpyrazine Derivative Protects Against Glutamate-Induced Cytotoxicity Through PGC1α/Nrf2 and PI3K/Akt Signaling Pathways.

Authors:  Haiyun Chen; Jie Cao; Zeyu Zhu; Gaoxiao Zhang; Luchen Shan; Pei Yu; Yuqiang Wang; Yewei Sun; Zaijun Zhang
Journal:  Front Neurosci       Date:  2018-08-15       Impact factor: 4.677

8.  A Novel Tetramethylpyrazine Derivative Prophylactically Protects against Glutamate-Induced Excitotoxicity in Primary Neurons through the Blockage of N-Methyl-D-aspartate Receptor.

Authors:  Shengquan Hu; Huihui Hu; Shinghung Mak; Guozhen Cui; Mingyuen Lee; Luchen Shan; Yuqiang Wang; Huangquan Lin; Zaijun Zhang; Yifan Han
Journal:  Front Pharmacol       Date:  2018-02-12       Impact factor: 5.810

9.  Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson's Disease In Vitro and In Vivo.

Authors:  Hefeng Zhou; Min Shao; Xuanjun Yang; Chuwen Li; Guozhen Cui; Cheng Gao; Lijun Di; Hanbing Zhong; Yuqiang Wang; Zaijun Zhang; Simon Ming-Yuen Lee
Journal:  Oxid Med Cell Longev       Date:  2019-11-14       Impact factor: 6.543

Review 10.  The Roles of Tetramethylpyrazine During Neurodegenerative Disease.

Authors:  Zeyu Meng; Huize Chen; Shengxi Meng
Journal:  Neurotox Res       Date:  2021-08-05       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.